Validated LC-MS/MS assay for quantification of the newly approved tyrosine kinase inhibitor, dacomitinib, and application to investigating its metabolic stability

• Ali S. Abdelhameed ,

  Roles Formal analysis, Funding acquisition, Resources, Validation, Writing – review & editing

  * E-mail: asaber@ksu.edu.sa (ASA); mzeidan@ksu.edu.sa (MWA)

  Affiliation Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia

  ⨯
• Adnan A. Kadi,

  Roles Formal analysis, Investigation, Resources, Software, Writing – review & editing

  Affiliation Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia

  ⨯
• Mohamed W. Attwa ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Supervision, Writing – original draft

  * E-mail: asaber@ksu.edu.sa (ASA); mzeidan@ksu.edu.sa (MWA)

  Affiliations Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia, Students’ University Hospital, Mansoura University, Mansoura, Egypt

  http://orcid.org/0000-0002-1147-4960

  ⨯
• Haitham AlRabiah

  Roles Data curation, Investigation, Supervision, Visualization, Writing – review & editing

  Affiliation Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia

  ⨯